NSN 6505-01-694-5728 · NIIN 016945728 · FSC 6505
NO DASHES 6505016945728
In Stock
MILRINONE LACTATE INJECTION
Drugs and Biologicals
Technical characteristics
6 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 1.0 |
| CSGS | ADMINISTRATION | INTRAVENOUS |
| FEAT | SPECIAL FEATURES | INDICATED FOR THE SHORT-TERM INTRAVENOUS TREATMENT OF PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE; CONTRAINDICATED IN PATIENTS WHO ARE HYPERSENSITIVE TO IT; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); AVOID FREEZING; EXPOSURE OF PHARMACEUTICAL PRODUCTS TO HEAT SHOULD BE MINIMIZED; AVOID EXCESSIVE HEAT; NO PRESERVATIVE IS ADDED; SUPPLIED AS 100 ML (200 MCG/ML) IN 5% DEXTROSE INJECTION SINGLE UNITS; PACKAGE OF 10. |
| CQGK | SECONDARY CONTAINER TYPE | PACKAGE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | MILRINONE LACTATE IN DEXTROSE INJECTION, 100ML, 10S |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
Cross-references
6 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| NDC00338-6010-48 | 1G026 |
| NDC00143-9719-10 | 32655 |
| 6505NCM217014 | 64616 |
| NDC00409-2776-23 | 72QE3 |
| NDC00409-2776-23 | 86491 |
| 1592912 | 89875 |